Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $9.9450 (-8.76%) ($9.9450 - $9.9450) on Tue. May. 24, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.79% (three month average) | RSI | 26 | Latest Price | $9.9450(-8.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -3% a day on average for past five trading days. | Weekly Trend | EDIT declines -10% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(65%) IWC(60%) IWO(58%) IBUY(57%) IWM(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.895% in a week (0% probabilities). VIXM(-24%) UUP(-15%) TBT(-10%) VXX(-9%) UNG(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.895% (StdDev 5.79%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-14.26(-243.39%) | Resistance Level | $12.12 | 5 Day Moving Average | $10.68(-6.88%) | 10 Day Moving Average | $10.87(-8.51%) | 20 Day Moving Average | $12.12(-17.95%) | To recent high | -53.4% | To recent low | 0% | Market Cap | $618m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |